Although previous association studies have demonstrated that the APOE4 allele is a risk factor for Alzheimer's disease (AD), its value for the prediction of AD in individuals is <100%. The limited predictive value of ⑀4 is also seen in multiply affected families where the ⑀4 allele is not tightly li
About the use of APOE in alzheimer's disease studies
✍ Scribed by Verpillat, Patrice; Margaritte-Jeannin, Patricia; Clerget-Darpoux, Fran�coise
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 2 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0148-7299
- DOI
- 10.1002/(sici)1096-8628(19980328)81:2<195::aid-ajmg13>3.0.co;2-c
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Recent evidence for mitochondrial mutations associated with Alzheimers disease (AD) suggests the possibility of maternal transmission of this illness. We investigated this hypothesis by examining, in a variety of ways, the risk of a primary progressive dementia (PPD) in the parents (n = 650) and sib
The apolipoprotein E (ApoE) genotype is a significant risk factor and modulator of age of onset of Alzheimer's disease (AD). We analyzed the effect of the ApoE genotype in two distinct early-onset familial AD groups: families with a mutation in the presenilin-1 gene (PS-1) on chromosome 14, and fami
Lipoprotein lipase (LPL) helps transfer lipids from lipoprotein particles to cells. In the brain, LPL is present in Alzheimer's disease (AD) amyloid plaques. LPL binds apolipoprotein E (ApoE) lipoprotein particles and low-density lipoprotein receptor-related protein (LRP), an ApoE receptor. Since po
We investigated a common signal peptide polymorphism in the ␣ 1-antichymotrypsin (ACT) gene in 125 sporadic Alzheimer disease (AD) patients and 141 healthy control subjects in Chinese Han population. We found no significant difference in the distribution of ACT polymorphism between AD cases and cont